373 related articles for article (PubMed ID: 26101868)
1. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
Li Q; Freeman LM; Rush JE; Laflamme DP
Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.
Jung S; Bohan A
Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980
[TBL] [Abstract][Full Text] [Related]
3. Myxomatous mitral valve disease in the miniature poodle: A retrospective study.
Meurs KM; Adin D; O'Donnell K; Keene BW; Atkins CE; DeFrancesco T; Tou S
Vet J; 2019 Feb; 244():94-97. PubMed ID: 30825902
[TBL] [Abstract][Full Text] [Related]
4. Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
Bagardi M; Ghilardi S; Zamarian V; Ceciliani F; Brambilla PG; Lecchi C
PLoS One; 2022; 17(7):e0266208. PubMed ID: 35816500
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic anatomy of the mitral valve in healthy dogs and dogs with myxomatous mitral valve disease.
Wesselowski S; Borgarelli M; Menciotti G; Abbott J
J Vet Cardiol; 2015 Jun; 17(2):97-106. PubMed ID: 26003902
[TBL] [Abstract][Full Text] [Related]
6. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC
J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827
[TBL] [Abstract][Full Text] [Related]
8. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H
PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
Wolf J; Gerlach N; Weber K; Klima A; Wess G
Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
[TBL] [Abstract][Full Text] [Related]
10. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
[TBL] [Abstract][Full Text] [Related]
11. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
Zhou Q; Wu Z; Li L; Zhou H; Chen Y; Guo S; Guo Y; Ma X; Zhang J; Feng W; Cui X; Qiu C; Xu M; Deng G
J Proteomics; 2023 Jun; 282():104924. PubMed ID: 37146676
[TBL] [Abstract][Full Text] [Related]
12. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
Druzhaeva N; Nemec Svete A; Ihan A; Pohar K; Domanjko Petrič A
J Vet Intern Med; 2021 Sep; 35(5):2112-2122. PubMed ID: 34236111
[TBL] [Abstract][Full Text] [Related]
14. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
Mangklabruks T; Surachetpong SD
J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease.
Chapel EH; Scansen BA; Schober KE; Bonagura JD
J Vet Intern Med; 2018 Jan; 32(1):64-71. PubMed ID: 29224256
[TBL] [Abstract][Full Text] [Related]
17. Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds.
Hulanicka M; Garncarz M; Parzeniecka-Jaworska M; Jank M
BMC Vet Res; 2014 Sep; 10():205. PubMed ID: 25253075
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
Khaki Z; Nooshirvani P; Shirani D; Masoudifard M
BMC Vet Res; 2022 Dec; 18(1):448. PubMed ID: 36564735
[TBL] [Abstract][Full Text] [Related]
19. Iron parameters analysis in dogs with myxomatous mitral valve disease.
Kumiega E; A Kobak K; Noszczyk-Nowak A; Kasztura M
BMC Vet Res; 2024 May; 20(1):210. PubMed ID: 38762716
[TBL] [Abstract][Full Text] [Related]
20. Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease.
Mavropoulou A; Guazzetti S; Borghetti P; De Angelis E; Quintavalla C
Vet J; 2016 May; 211():45-51. PubMed ID: 27033593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
